Company news
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) news
Every Collegium Pharmaceutical, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Collegium to Report Second Quarter 2026 Financial Results on August 6, 2026
July 23, 2026
DivcoWest Welcomes Collegium Pharmaceutical to One Lincoln
July 20, 2026
Collegium Pharmaceutical Announces New Corporate Headquarters at One Lincoln in Boston
July 20, 2026
Collegium Pharmaceutical Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 5, 2026
Collegium to Participate in 2026 Jefferies Global Healthcare Conference
May 27, 2026
Collegium Completes Acquisition of AZSTARYS® from Corium Therapeutics
May 12, 2026
Collegium Reports First Quarter 2026 Financial Results and Highlights Recent Company Progress
May 7, 2026
Collegium to Report First Quarter 2026 Financial Results on May 7, 2026
April 23, 2026
Collegium to Acquire AZSTARYS from Corium Therapeutics, Strengthening Position in ADHD and Accelerating Growth Trajectory
March 20, 2026
Collegium to Acquire AZSTARYS® from Corium Therapeutics, Strengthening Position in ADHD and Accelerating Growth Trajectory
March 19, 2026
Collegium to Present New Real-World Data at PainConnect 2026
March 5, 2026
Paris Hilton Shares Her Experience with JORNAY PM and Launches New 'Embrace Your Sparkle' Campaign with Collegium to Empower the ADHD Com...
March 3, 2026
Collegium Reports Fourth Quarter and Full-Year 2025 Financial Results
February 26, 2026
Boston Legacy FC Announces Sensory Room Sponsorship with Collegium Pharmaceutical
February 23, 2026
Collegium to Report Fourth Quarter and Full-Year 2025 Financial Results on February 26, 2026
February 12, 2026
Collegium to Present Four Real-World Data Posters at APSARD 2026 Annual Conference
January 15, 2026
Collegium Provides 2026 Financial Guidance and Business Update
January 8, 2026
Collegium Announces the Closing of $980 Million Syndicated Credit Facility
December 30, 2025
Dyne Therapeutics Appoints Vikram Karnani to Board of Directors
December 23, 2025
Collegium to Participate in Upcoming Investor Conferences
November 12, 2025
Collegium Reports Third Quarter 2025 Financial Results; Raises 2025 Guidance
November 6, 2025
Knight Therapeutics Announces Launch of JORNAY PM™ in Canada
October 30, 2025
Paris Hilton Collaborates with Collegium Pharmaceutical to Share Her Personal ADHD Journey and Experience with Treatment
October 29, 2025
Collegium to Report Third Quarter 2025 Financial Results on November 6, 2025
October 23, 2025
Collegium Announces Poster Presentations at the American Academy of Child & Adolescent Psychiatry and Neuroscience Education Institute Co...
October 22, 2025
Collegium to Celebrate 10-Year Anniversary with Nasdaq Opening Bell Ringing
October 13, 2025
Collegium to Present Nine Real-World Data Posters at PAINWeek 2025 Annual Meeting
August 25, 2025
Collegium Reports Second Quarter 2025 Financial Results; Raises 2025 Outlook
August 7, 2025
Collegium to Report Second Quarter 2025 Financial Results on August 7, 2025
July 24, 2025
Collegium Announces $150 Million Share Repurchase Program
July 7, 2025
Collegium Announces $25 Million Accelerated Share Repurchase Program
May 12, 2025
Collegium Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress
May 8, 2025
Collegium to Report First Quarter 2025 Financial Results on May 8, 2025
April 24, 2025
Collegium to Participate in 24th Annual Needham Virtual Healthcare Conference
April 1, 2025
Collegium to Present Real-World Data at PainConnect 2025, the American Academy of Pain Medicine’s Annual Meeting
March 27, 2025
Collegium Announces Updates to its Board of Directors and Executive Leadership Team
March 17, 2025
Collegium Announces Poster Presentations at the 2025 National Association of Pediatric Nurse Practitioners National Conference on Pediatr...
March 10, 2025
Collegium Reports Record Fourth Quarter and Full-Year 2024 Financial Results
February 27, 2025
Collegium to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025
February 13, 2025
Collegium Appoints Nancy S. Lurker to its Board of Directors
February 5, 2025
Collegium Provides 2025 Financial Guidance and Business Update
January 8, 2025
Collegium Appoints Vikram Karnani as Chief Executive Officer
November 7, 2024
Collegium Reports Record Third Quarter 2024 Financial Results
November 7, 2024
Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024
October 24, 2024
Collegium Completes Acquisition of Ironshore Therapeutics
September 4, 2024
Collegium to Participate in H.C. Wainwright 26th Annual Global Investment Conference
August 30, 2024
Collegium Announces Eight Poster Presentations at PAINWeek Conference 2024
August 28, 2024
Collegium Reports Second Quarter 2024 Financial Results
August 8, 2024
Collegium to Acquire Ironshore Therapeutics, Expanding into Neurology
July 29, 2024
Collegium to Report Second Quarter 2024 Financial Results on August 8, 2024
July 25, 2024